Literature DB >> 2395092

Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution.

J J Ferry1, J H Shepard, G J Szpunar.   

Abstract

Twenty-two healthy male volunteers completed a four-way, multiple-dose, randomized crossover study to determine the relationship between contact time of applied drug on the scalp and minoxidil absorption from a 2% topical solution. One milliliter of solution was applied twice daily over 150 cm2 of bald scalp to each subject for 6 days. Unabsorbed drug was washed off the scalp after 1, 2, 4, and 11.5 h of contact time in each of four treatments. Cumulative urinary excretion profiles within steady-state, 12-h dosing intervals were well described by straight lines for all treatments, indicating that systemic minoxidil elimination was rate controlled by constant, zero-order percutaneous drug absorption. The extent of minoxidil absorption, expressed as steady-state urinary excretion of unchanged minoxidil, minoxidil glucuronide, or the sum of these, increased in a disproportionate manner with increase in contact time of drug on the scalp. Relative to the amount absorbed after a contact time of 11.5 h, absorption was approximately 50% complete by 1 h and greater than 75% complete by 4 h. This suggests that minoxidil absorption from the vehicle into skin occurs rapidly relative to diffusion through skin. The rate of minoxidil absorption from vehicle into skin was characterized as nonlinear, whereas minoxidil excretion into urine was rate controlled by diffusion from one or more components of the skin which apparently serve as a reservoir, or depot, for minoxidil.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395092     DOI: 10.1002/jps.2600790605

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.

Authors:  J Vaigunda Ragavendran; André Laferrière; Wen Hua Xiao; Gary J Bennett; Satyanarayana S V Padi; Ji Zhang; Terence J Coderre
Journal:  J Pain       Date:  2013-01       Impact factor: 5.820

Review 2.  Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.

Authors:  V M Meidan; E Touitou
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Pharmacological Management of Pattern Hair Loss.

Authors:  Sandeep Suresh Sattur; Indu Sandeep Sattur
Journal:  Indian J Plast Surg       Date:  2021-12-13

4.  Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.

Authors:  Ramesh Venkatesh; Arpitha Pereira; Kushagra Jain; Naresh Kumar Yadav
Journal:  BMC Ophthalmol       Date:  2020-06-05       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.